ID24870A - Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi - Google Patents

Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi

Info

Publication number
ID24870A
ID24870A IDW20000183A ID20000183A ID24870A ID 24870 A ID24870 A ID 24870A ID W20000183 A IDW20000183 A ID W20000183A ID 20000183 A ID20000183 A ID 20000183A ID 24870 A ID24870 A ID 24870A
Authority
ID
Indonesia
Prior art keywords
salt
physiology
complexes
accepted
vanadium compounds
Prior art date
Application number
IDW20000183A
Other languages
English (en)
Indonesian (id)
Inventor
Conradus Ghosal Gho
Original Assignee
Gho St Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gho St Holding Bv filed Critical Gho St Holding Bv
Publication of ID24870A publication Critical patent/ID24870A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20000183A 1997-07-29 1998-07-29 Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi ID24870A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1006681A NL1006681C2 (nl) 1997-07-29 1997-07-29 Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.

Publications (1)

Publication Number Publication Date
ID24870A true ID24870A (id) 2000-08-31

Family

ID=19765422

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000183A ID24870A (id) 1997-07-29 1998-07-29 Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi

Country Status (22)

Country Link
US (2) US6579540B1 (de)
EP (1) EP1001792B1 (de)
JP (1) JP2001511454A (de)
CN (1) CN1104244C (de)
AT (1) ATE253373T1 (de)
AU (1) AU738701B2 (de)
BR (1) BR9811298A (de)
CA (1) CA2298645C (de)
CZ (1) CZ299716B6 (de)
DE (1) DE69819514T2 (de)
DK (1) DK1001792T3 (de)
EA (1) EA002574B1 (de)
ES (1) ES2207851T3 (de)
ID (1) ID24870A (de)
IL (2) IL134259A0 (de)
NL (1) NL1006681C2 (de)
NO (1) NO20000446L (de)
NZ (1) NZ502613A (de)
PL (1) PL338415A1 (de)
PT (1) PT1001792E (de)
TR (1) TR200000349T2 (de)
WO (1) WO1999006056A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1006681C2 (nl) * 1997-07-29 1999-02-08 Gho St Holding Bv Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.
US8192994B2 (en) * 1998-02-10 2012-06-05 Angros Lee H Method of applying a biological specimen to an analytic plate
AU1898700A (en) * 1999-12-20 2001-07-03 Gho'st Holding B.V. Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and NA+/H+ exchange inhibitor
WO2003041703A2 (en) * 2001-11-16 2003-05-22 Gho Holding B.V. Use of a flavonoid for the treatment of burns
WO2008092935A2 (en) 2007-01-31 2008-08-07 Basf Plant Science Gmbh Plants having enhanced yield-related traits and/or increased abiotic stress resistance, and a method for making the same
EP2228386B1 (de) 2007-05-03 2015-03-18 BASF Plant Science GmbH Pflanzen mit verbesserten Eigenschaften bezüglich des Ertrags und Verfahren zu ihrer Herstellung
EP2173884B1 (de) 2007-07-20 2013-09-18 BASF Plant Science GmbH Pflanzen mit verstärkten ertragsbezogenen merkmalen und verfahren zur herstellung davon
AR067748A1 (es) 2007-07-31 2009-10-21 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas
AU2008320931B2 (en) 2007-10-29 2014-09-25 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
BRPI0912244A2 (pt) 2008-05-05 2016-10-11 Basf Plant Science Gmbh método para intensificar as características relacionadas com o rendimento em plantas em relação às plantas de controle, constructo, uso do mesmo, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica, planta transgênica, partes colhíveis de uma planta, produtos, e, uso de um ácido nucleico.
US20100078320A1 (en) * 2008-09-26 2010-04-01 Applied Materials, Inc. Microwave plasma containment shield shaping
BR112012017535A2 (pt) 2010-01-15 2019-09-24 Of Medicine And Dentistry Of New Jersey University uso de compostos de vanádio para cicatrização de osso
EP2648718B1 (de) 2010-12-10 2019-05-08 Rutgers, the State University of New Jersey Implantierbare vorrichtungen mit insulin-mimetikum-verbundstoffbeschichtung und verfahren dafür
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
BR112013022907A2 (pt) * 2011-03-07 2016-09-13 Cfm Pharma Holding Bv composição farmacêutica
US9931348B2 (en) * 2011-07-06 2018-04-03 Rutgers, The State University Of New Jersey Vanadium compounds as therapeutic adjuncts for cartilage injury and repair
PL231079B1 (pl) 2012-11-07 2019-01-31 Univ Jagiellonski Kompleksy wanadu z hydrazydohydrazonami, preparaty farmaceutyczne oraz zastosowanie kompleksów wanadu z hydrazydohydrazonami
NL2010222C2 (en) * 2013-02-01 2014-08-04 Conradus Ghosal Gho Composition and method for generating a desired cell type and/or tissue type from hair follicular stem cells.
NL2019605B1 (en) * 2017-09-22 2019-03-28 Cfm Pharma Holding B V Vanadyl and vanadate for use in reducing stress-induced metabolic derangement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012563A1 (en) * 1989-04-24 1990-11-01 Board Of Regents, The University Of Texas System Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
US5565491A (en) 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
FR2729957B1 (fr) * 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
NL1006681C2 (nl) * 1997-07-29 1999-02-08 Gho St Holding Bv Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.

Also Published As

Publication number Publication date
TR200000349T2 (tr) 2000-09-21
PT1001792E (pt) 2004-03-31
EP1001792B1 (de) 2003-11-05
NO20000446D0 (no) 2000-01-28
IL134259A0 (en) 2001-04-30
EA002574B1 (ru) 2002-06-27
IL134259A (en) 2010-02-17
CA2298645C (en) 2004-05-18
WO1999006056A1 (en) 1999-02-11
BR9811298A (pt) 2000-08-29
EP1001792A1 (de) 2000-05-24
DK1001792T3 (da) 2004-01-19
AU8650598A (en) 1999-02-22
PL338415A1 (en) 2000-11-06
NZ502613A (en) 2001-08-31
AU738701B2 (en) 2001-09-27
US6579540B1 (en) 2003-06-17
NO20000446L (no) 2000-03-24
ATE253373T1 (de) 2003-11-15
ES2207851T3 (es) 2004-06-01
EA200000176A1 (ru) 2000-10-30
DE69819514T2 (de) 2004-09-23
CZ299716B6 (cs) 2008-10-29
CN1270525A (zh) 2000-10-18
DE69819514D1 (de) 2003-12-11
CA2298645A1 (en) 1999-02-11
CN1104244C (zh) 2003-04-02
US20030211170A1 (en) 2003-11-13
NL1006681C2 (nl) 1999-02-08
JP2001511454A (ja) 2001-08-14
CZ2000326A3 (cs) 2000-07-12

Similar Documents

Publication Publication Date Title
PL338415A1 (en) Application of physiologically compatible vanadium compounds, salts and complexes
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
NZ502280A (en) Combination therapy comprising atorvastatin and an antihypertensive agent
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
EP1008344A4 (de) Neue verwendung von dikaffeoylchinasäure zur behandlung von hepatitis b und retroviraler krankenheiten, und die neuen kaffeoylchinasäurederivate
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
IL108356A0 (en) Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
IL120495A0 (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
GEP20043231B (en) Resorcinol Composition
RU96104062A (ru) Средство "витадерм" в комплексной терапии ожоговых ран
AU7941294A (en) Composition for the treatment or prevention of herpes
WO2002076393A3 (en) Antiagionecic, antitumor, chemopreventative agents
MY143194A (en) Topical pharmaceutical compositions for healing wounds
TR200200111T2 (tr) Neoplazmalar için terapötik ve profilaktik maddeler
RU94045140A (ru) Фармацевтическая композиция для профилактики или лечения вирусных заболеваний, способ ее получения и применение антагониста брадикинина или его физиологически переносимой соли в качестве средства для профилактики или лечения вирусных заболеваний
WO2001045717A3 (en) Pharmaceutical composition comprising a vanadium compound and at least a component selected from a na+/h+ exchanger, cyclo-oxygenase inhibitors and caspase inhibitors
GR1004434B (el) Χρησηατουαdiclofenacαhααποδεκτωνααλατωνααυτουαγιαατηνααντιμετωπισηατωναεγκαυματων
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada
DE60235965D1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
AU8900498A (en) Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения